← Eichor
Study identifier: NCT04524091 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prediction of Inspiratory Effort Response to High PEEP in Patients Recovering From ARDS

Condition: Acute Respiratory Distress Syndrome  ·  Sponsor: Sanatorio Anchorena San Martin

PhaseN/A
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Spontaneous breathing during the transition from controlled to assisted ventilation in ARDS may be harmful, as high respiratory drive can generate large transpulmonary pressure swings and worsen lung injury. Higher PEEP may mitigate this by reducing inspiratory effort and lung stress, but patient response is variable and difficult to predict. While improved lung compliance appears to mediate the protective effects of PEEP, its bedside assessment is complex. Preclinical data suggest that changes in compliance are inversely reflected by changes in respiratory rate, but this relationship and its clinical utility in ARDS patients remain unclear.

This description comes directly from the study's public registry record.

Talk to the study team

Joaquin Pérez, PT  ·  +542245505907  ·  licjoaquinperez@hotmail.com

Javier H Dorado, PT  ·  +54 1141644262  ·  javierhdorado@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Sanatorio Anchorena de San MartinSan Martín, Buenos Aires, ArgentinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04524091